Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Bridging Study: Comparing Two Sci-B-Vac Batches in Healthy Adults

Next Previous
X
Search
Trial Profile

A Bridging Study: Comparing Two Sci-B-Vac Batches in Healthy Adults

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jun 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary)
  • Indications Hepatitis B
  • Focus Registrational; Therapeutic Use
  • Acronyms A Bridging Study
  • Sponsors VBI Vaccines

    • Most Recent Events

    • 26 Jun 2021 Results assessing speed to seroprotection, immunogenicity and safety of prophylactic HBV vaccine from five clinical trials: PROTECT, CONSTANT, SG-005-05, 38-13-040 and SciB018 presented at The International Liver Congress 2021
    • 08 Jun 2021 Results (n=398) assessing efficacy, immunogenicity and safety among two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac compared with Engerix-B in healthy asian adults, published in the Vaccine.
    • 25 Oct 2020 Results (n=3668) of five studies (PROTECT, CONSTANT, SG-005-05, 38-13-040 and SciB018) assessing rapid onset of seroprotection rates in young adults immunized with a tri-antigenic hepatitis B virus vaccine compared to a mono-antigenic HBV vaccine, presented at the IDWeek 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top